Beryl Drugs Ltd. reported unaudited earnings results for the third quarter and nine months ended December 31, 2012. For the quarter, the company reported profit from operations before other income, interest and tax of INR 2.876 million compared to INR 1.793 million reported a year ago. Net profit was INR 2.516 million or INR 0.49 per basic and diluted share compared to net profit of INR 1.660 million or INR 0.32 per basic and diluted share reported a year ago. Income from sales was INR 45.284 million compared to INR 22.390 million reported a year ago. Profit before tax was INR 2.816 million against INR 1.760 million a year ago.

For the nine months, the company reported profit from operations before other income, interest and tax of INR 8.114 million compared to INR 12.281 million reported a year ago. Net profit was INR 6.375 million or INR 1.24 per basic and diluted share compared to net profit of INR 10.750 million or INR 2.10 per basic and diluted share reported a year ago. Income from sales was INR 134.912 million compared to INR 72.573 million reported a year ago. Profit before tax was INR 7.975 million against INR 1.250 million a year ago.